Trial Profile
A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Chemotherapy and Radiotherapy
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2014
Price :
$35
*
At a glance
- Drugs Golotimod (Primary)
- Indications Mucositis
- Focus Therapeutic Use
- Sponsors SciClone Pharmaceuticals
- 25 Sep 2014 New trial record